| Application no. and date | 10185340.6 (espacenet) (Federated) (European Patent Register), 20041105 | | Patent/reg. no. and date | DK/EP 2348051, 20181219 | | Publication date | 20110727 | | Priority no. and date | US 517096 P, 20031105 | | EP pub. no. and date |
EP 2348051 20110727 | | Effective date | | | Applicant/owner | Roche Glycart AG, Wagistrasse 10
8952 Schlieren, CH | | Applicant ref. no. | P60825DK02 | | Inventor | BRUNKER, Peter, Burgwiesenstrasse 3c
8335 Hittnau, CH,
MOSSNER, Ekkehard, Felsenburgweg 5
8280 Kreuzlingen, CH,
Ferrara Koller, Claudia, Göblistrasse 12
6300 Zug, CH,
Püntener, Ursula, 44 Darlington Gardens
Southampton SO15 7QJ, GB,
Umana, Pablo, Felsenrainstrasse 28
8032 Wollerau, CH,
Suter, Tobias, Grenzacher Str. 124
4070 Basel, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , C07K 16/28 (2006.01) , C12N 15/11 (2006.01) , C12N 15/63 (2006.01) , C12N 9/10 (2006.01) | | Title | CD20 antistoffer med øget fc-receptorbindingsaffinitet og effektorfunktion | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
